Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth

Urological Research

Volumn 35, Issue 6, 2007, Pages 277-285

  Webber, Dawn ^a   Rodgers, Allen L ^a   Sturrock, Edward D ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Calcium oxalate; Crystallization; Glycosylation; Kidney stones; Protein; Prothrombin fragment 1

Indexed keywords

CALCIUM OXALATE; GLYCOPROTEIN; PROTHROMBIN;

ARTICLE; CRYSTALLIZATION; ENZYME MODIFICATION; GLYCOSYLATION; PLASMA; PRIORITY JOURNAL; UROLITHIASIS;

CALCIUM OXALATE; CRYSTALLIZATION; GLYCOSYLATION; HUMANS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PROTHROMBIN; UROLITHIASIS;

EID: 36348962532     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-007-0119-z     Document Type: Article

References (30)

1. Khan S, Kok DJ (2004) Modulators of urinary stone formation. Front Biosci 9:1450-1482
2. Ryall RL (2004) Macromolecules and urolithiasis: parallels and paradoxes. Nephron Physiol 98:37-42
3. Hallson PC, Choong SK, Kasidas GP, Samuell CT (1997) Effects of Tamm-Horsfall protein with normal and reduced sialic acid content upon the crystallization of calcium phosphate and calcium oxalate in human urine. Br J Urol 80:533-538
4. Chen WC, Lin HS, Chen HY, Shih CH, Li CW (2001) Effects of Tamm-Horsfall protein and albumin on calcium oxalate crystallization and importance of sialic acids. Mol Urol 5:1-5
5. Boskey AL (1995) Osteopontin and related phosphorylated sialoproteins: effects on mineralization. Ann NY Acad Sci 760:249-256
6. Konya E, Amasaki N, Umekawa T, Iguchi M, Kurita T (2002) Influence of urinary sialic acid on calcium oxalate crystal formation. Urol Int 68:281-285
7. Gericke A, Qin C, Spevak L, Fujimoto Y, Butler WT, Sorensen ES, Boskey AL (2005) Importance of phosphorylation for osteopontin regulation of biomineralization. Calcif Tissue Int 77:45-54
8. Atmani F, Lacour B, Jungers P, Drueke T, Daudon M (1994) Reduced inhibitory activity of uronic-acid-rich protein in urine of stone formers. Urol Res 22:257-260
9. Nakagawa Y, Ahmed MA, Hall SL, Deganello S, Coe FL (1987) Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. J Clin Invest 79:1782-1787
10. Grover PK, Moritz RL, Simpson RJ, Ryall RL (1998) Inhibition of growth and aggregation of calcium oxalate crystals in vitro. A comparison of four human proteins. Eur J Biochem 253:637-644
11. Webber D, Rodgers AL, Sturrock ED (2002) Synergism between urinary prothrombin fragment 1 and urine: a comparison of inhibitory activities in stone-protein and stone-free population groups. Clin Chem Lab Med 40:930-936
12. Ryall RL, Grover PK, Stapleton AM, Barrell DK, Tang Y, Moritz RL, Simpson RJ (1995) The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. Clin Sci 89:533-541
13. Grover PK, Ryall RL (2002) Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity. Clin Sci 102:425-434
14. Grover PK, Ryall RL (1999) Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro. Eur J Biochem 263:50-56
15. Webber D, Radcliffe CM, Royle L, Tobiasen G, Merry AH, Rodgers AL, Sturrock ED, Wormald MR, Harvey DJ, Dwek RA, Rudd PM (2006) Sialylation of urinary prothrombin fragment 1 is different in controls and stone-formers and in white and black population groups. FEBS J 273:3024-3037
16. Bezeaud A, Guillin M-C (1984) Quantitation of prothrombin activation products in human urine. Br J Haem 58:597-606
17. Hess B, Mienhardt U, Zipperle L, Giovanoli R, Jaeger P (1995) Simultaneous measurements of calcium oxalate crystal nucleation and aggregation: impact of various modifiers. Urol Res 23:231-238
18. Asplin JR, Bushinsky DA, Singharetnam W, Riordon D, Parks JH, Coe FL (1997) Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int 51:640-645
19. Chang LC, Lin HS, Chen WC (2001) The reappraisal of nephrocalcin-its role in the inhibition of calcium oxalate crystal growth and interaction with divalent metal ions. Urol Res 29:89-93
20. Pak CYC, Ohata M, Holt K (1975) Effect of diphosphonate on crystallization of calcium oxalate in vitro. Kidney Int 7:154-160
21. Walton RC, Kavanagh JP, Heywood BR, Rao PN (2005) The association of different urinary proteins with calcium oxalate hydromorphs. Evidence for non-specific interactions. Biochim Biophys Acta 1723:175-183
22. Barrabes S, Pages-Pons L, Radcliffe CM, Tabares G, Fort E, Royle L, Harvey DJ, Moenner M, Dwek RA, Rudd PM, De Llorens R, Peracaula R (2007) Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. Glycobiology 17:388-400
23. Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C (2006) Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy. J Am Soc Nephrol 17:3529-3539
24. Wopereis S, Abd Hamid UM, Critchley A, Royle L, Dwek RA, Morava E, Leroy JG, Wilcken B, Lagerwerf AJ, Huijben KM, Lefeber DJ, Rudd PM, Wevers RA (2006) Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria. Biochim Biophys Acta 1762:598-607
25. Kavanagh JP (1992) Methods for the study of calcium oxalate crystallisation and their application to urolithiasis research. Scanning Microsc 6:685-704
26. Fleisch H (1990) Role of inhibitors and promoters of crystal nucleation, growth and aggregation in the formation of calcium stones. In: Wickham JEA, Buck AC (eds) Renal tract stone: metabolic basis and clinical practice. Longman, London, pp 295-306
27. Finlayson B (1978) Physicochemical aspects of urolithiasis. Kidney Int 13:344-360
28. Kavanagh JP (2006) Supersaturation and renal precipitation: the key to stone formation? Urol Res 34:81-85
29. Kok DJ, Papapoulos SE, Bijvoet OLM (1990) Crystal agglomeration is a major element in calcium oxalate urinary stone formation. Kidney Int 37:51-56
30. Finlayson B (1977) Where and how does urinary stone disease start? In: van Reen R (ed) Idiopathic urinary bladder stone disease, vol 37. US Government Printing Office, Washington, pp 7-31